Letter from FDA Commissioner Hamburg on Generic Abuse-Deterrent Formulations of Prescription Opioid Products

April 16, 2013

To read the March 5, 2013 letter to FDA, click here.

To read FDA's April 16, 2013, response, click here.

Letter Type: